Compression after sclerotherapy: what the 2019 guideline supports
The guideline suggests compression after sclerotherapy, but the evidence remains uncertain. There is no guarantee of less stains or ideal duration for everyone.
View the video lessonThe most frequent question after a telangiectasis sclerotherapy session is whether the sock is necessary and for how long. The joint guideline of 2019 dedicates section 3 to this and brings together 18 publications: a systematic review, two guidelines, a consensus, two opinions, four randomized trials and eight observational studies.
The Rational
Immediate compression approaches the walls of the treated vessel, increases contact with sclerosing and reduces the formation of intraluminal thrombus — the substrate of hyperpigmentation. This is the physiological argument to consider it an integral part of treatment.
Tests in telangiectasias
Kern et al. randomized 100 women with telangiectasis and reticular veins to sock from 23 to 32 mm Hg daily for 3 weeks or no compression after a single liquid sclerotherapy session. Photographs evaluated by two blind reviewers, on average 52 days later, showed greater disappearance of the vessels with the sock, with no significant difference in pigmentation or matting.

Weiss et al. followed 40 patients: 10 without compression and three subgroups of 10 with sock for 3 days, 1 week or 3 weeks. All compression groups improved more than control in 6 weeks; the 3-week continuous group had the greatest improvement, and the 1- and 3-week groups had the lowest hyperpigmentation.

The counterpoint: saphenous stem foam
In a two-center trial, 60 patients with great and great saphenous vein insufficiency treated with ultrasound-guided foam received compression stocking 15 to 20 mm Hg for 3 weeks or no compression. On 14 and 28, evaluated by independent examiners, there was no difference in efficacy, adverse effects, satisfaction, symptoms or quality of life. The result of telangiectasis does not automatically transfer to the trunk.
In the prospective basis of Thomasset, with 126 patients treated with foam, the only factor associated with occlusion of the target vessel was adherence to post-procedure compression – a variable that most studies do not even report.
What the directive does not authorize to state
Recommendation 3.1 is grade 2, evidence C: suggestion, not rule. 3.2 declares the absence of convincing evidence on duration and refers to clinical judgment. The studies are heterogeneous in modality, pressure and time; no trial separated outcomes from cosmetic and symptomatic patients, and adherence was rarely measured. There's no basis to promise pressure or optimal duration.
Later Critical Reading
Kern's original assay found no significant difference in pigmentation, contrary to what may suggest the synthesis of the guideline. The subsequent Cochrane review found no clear benefit of compression in clearance or hyperpigmentation. The historical recommendation is not equivalent to a guarantee of benefit or a universal duration.
Content addressed exclusively to health professionals. No individual result is guaranteed: the indication depends on clinical evaluation and imaging examination of each patient (CFM 2,336/2023).